Fund V. L.P. Omega Buys 450,000 Shares of Kronos Bio, Inc. (NASDAQ:KRON) Stock
Kronos Bio, Inc. (NASDAQ:KRON) major shareholder Fund V. L.P. Omega bought 450,000 shares of the stock in a transaction dated Wednesday, October 14th. The shares were acquired at an average price of $19.00 per share, with a total value of $8,550,000.00. Following the completion of the acquisition, the insider now directly owns 2,437,662 shares of the company’s stock, valued at approximately $46,315,578. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.
Kronos Bio stock opened at $32.06 on Friday. Kronos Bio, Inc. has a twelve month low of $25.50 and a twelve month high of $34.90.
About Kronos Bio
See Also: Google Finance Portfolio Tips and Tricks
Receive News & Ratings for Kronos Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kronos Bio and related companies with MarketBeat.com's FREE daily email newsletter.